TCTR20211222005尚未招募不适用
Detection of Chloroquine or Hydroxychloroquine Retinopathy by Visual Field 10-2 VS Visual Field 24-2 Combined with Retinal Imaging in Chiang Mai University Hospital
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.18 years old or older, 2.male and female, 3.taking chloroquine or hydroxychloroquine, 4.visiting ophthalmic OPD of CMU hospital for retinopathy screening during 1st December 2021 to 28th February 2024
排除标准
- •1.retinal disease, 2.macular disease, 3.retinal vascular disease, 4.neuro-oph disease, 5.glaucoma or glaucoma suspected, 6.unable to perform visual field test
研究者
相似试验
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)Profliaxis of SARS-CoV-2 infectionMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-001441-39-ITIVERSITY OF OXFORD40,000
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of COVID-19 (COPCOV)EUCTR2020-001441-39-GBniversity of Oxford10,000
已完成
不适用
A study to estimate drug levels in health care workers on COVID infection prophylaxisCTRI/2020/05/025466orwich Clinical Services PvtLtd22
进行中（未招募）
2 期
The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirusRBR-8h7q82niversidade Federal de Roraima
招募中
3 期
Hydroxychloroquine for prevention of COVID-19Coronavirus diseasePACTR202009786901147Dr. William Schilling1,600